Weiß nicht, ob wir das schon hier hatten;
Das ist die 2seventy/JW - MAGE-A4-Studie
classic.clinicaltrials.gov/ct2/show/NCT06170294
"Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation:§N/A
Intervention Model: Single Group Assignment
Masking:§None (Open Label)
Primary Purpose: Treatment
Official Title: A Single-arm, Open-label, Dose Exploratory Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Autologous Humanized MAGE-A4-directed T Cell Receptor Engineered T Cell (JWTCR001) in Patients With Advanced Solid Tumors
Estimated Study Start Date : January 1, 2024
Estimated Primary Completion Date : December 31, 2025
Estimated Study Completion Date : December 31, 2028"
(Verkleinert auf 63%)